Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
14.76
+0.01 (0.07%)
At close: Nov 11, 2026, 4:00 PM EST
14.50
-0.26 (-1.76%)
After-hours: Nov 11, 2026, 4:34 PM EST
Jasper Therapeutics Employees
The last reported number of employees for Jasper Therapeutics was 22. That makes Jasper Therapeutics the 38,094th largest employer in the world and 5,432nd in the United States.
Employees
22
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
16.37M
No historical employees data available.
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Seres Therapeutics | 66 |
| Bolt Biotherapeutics | 23 |
| Quantum BioPharma | 17 |
| Context Therapeutics | 15 |
| BioVie | 13 |
| Actuate Therapeutics | 12 |
| Cocrystal Pharma | 10 |
JSPR News
- 2 days ago - Jasper Therapeutics, Inc. Announces Results of the Offer to Purchase Relating to Its Warrants - GlobeNewsWire
- 5 days ago - Jasper Therapeutics trading halted, news pending - TheFly
- 7 days ago - Jasper Therapeutics announces 1-for-30 reverse stock split - TheFly
- 7 days ago - Jasper Therapeutics Announces 1-for-30 Reverse Stock Split - GlobeNewsWire
- 23 days ago - Jasper Therapeutics Proxy statement: Proxy filing - Filings
- 27 days ago - Jasper Therapeutics completes enrollment in IgAN cohort of KP104 study - TheFly
- 27 days ago - Jasper Therapeutics Announces Completion of Enrollment in First Cohort of Phase 2 Renal Basket Study Evaluating Vensobafusp Alfa (KP104) in IgA Nephropathy - GlobeNewsWire
- 4 weeks ago - Jasper Therapeutics files to sell 284.01M shares of common stock for holders - TheFly